Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Functional Impairment Network-Guided Individualized Transcranial Magnetic Stimulation for Behavioral and Psychological Symptoms in Alzheimer's Disease (NET-BPSD): A Randomized, Double-blind, Sham-Controlled Trial

NCT07692542 is registered in ClinicalTrials.gov with Anhui Medical University as lead sponsor.

NCT NCT07692542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07692542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Functional Impairment Network-Guided Individualized Transcranial Magnetic Stimulation for Behavioral and Psychological Symptoms in Alzheimer's Disease (NET-BPSD): A Randomized, Double-blind, Sham-Controlled Trial
Lead sponsor
Anhui Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
February 28, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

behavioral and psychological symptoms in alzheimer's disease, individualized navigation, transcranial magnetic stimulation